HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of the transcriptional signature of C/EBPbeta isoforms (LAP/LIP) in Hep3B cells: implication of LIP in pro-survival functions.

AbstractBACKGROUND & AIMS:
C/EBPbeta is an important mediator of several cellular processes, such as differentiation, proliferation, and survival of hepatic cells. However, a complete catalog of the targets of C/EBPbeta or the mechanism by which this transcription factor regulates certain liver-dependent pathways has not been clearly determined. Two major natural isoforms of this transcription factor exist: the liver-enriched activating protein (LAP) and the liver-enriched inhibitory protein (LIP), a functional LAP antagonist. In this study, we used the opposing transcriptional effects driven by LAP and LIP to determine the genuine C/EBPbeta molecular signature in the Hep3B human hepatoma cell line. We subsequently investigated the role of each of the LAP and LIP isoforms in drug-induced Hep3B cell death.
METHODS:
We engineered Hep3B cells with regulated LAP or LIP expression using the Tet-off expression system. The genes that showed inverse regulation by LAP and LIP were identified by cDNA array analysis. The cohort of direct-C/EBPbeta-targets was distinguished from indirect-targets by ChIP-on-chip analysis.
RESULTS:
We characterized 676 genes by this approach. Among these genes, 39 are novel direct targets of C/EBPbeta. Eleven of these new direct targets are involved in cell survival, suggesting critical roles for LAP/LIP isoforms in this cellular process. Therefore, we examined the effects of LAP and LIP over-expression on cell survival. We show that LIP promotes survival in staurosporine- or taxol-induced Hep3B cell death.
CONCLUSIONS:
Our study provides new molecular and cellular insights into the role of C/EBPbeta in cells of hepatic origin.
AuthorsGaëlle Saint-Auret, Jean-Louis Danan, Martine Hiron, Céline Blache, Eric Sulpice, Simon Tendil, Maryvonne Daveau, Xavier Gidrol, Jean-Philippe Salier
JournalJournal of hepatology (J Hepatol) Vol. 54 Issue 6 Pg. 1185-94 (Jun 2011) ISSN: 1600-0641 [Electronic] Netherlands
PMID21145827 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Chemical References
  • CCAAT-Enhancer-Binding Protein-beta
  • Protein Isoforms
  • Staurosporine
  • Paclitaxel
Topics
  • CCAAT-Enhancer-Binding Protein-beta (genetics, physiology)
  • Carcinoma, Hepatocellular (genetics, pathology)
  • Cell Death (drug effects, genetics, physiology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects, genetics, physiology)
  • Gene Expression Profiling
  • Genetic Engineering
  • Humans
  • Liver Neoplasms (genetics, pathology)
  • Models, Biological
  • Oligonucleotide Array Sequence Analysis
  • Paclitaxel (pharmacology)
  • Protein Isoforms (genetics, physiology)
  • Staurosporine (pharmacology)
  • Transcription, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: